Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,168 | 46,383 | 71,956 | 17,710 | 21,666 |
| Depreciation Amortization | 3,948 | -1,078 | 1,683 | 2,839 | 3,172 |
| Income taxes - deferred | 10,608 | -3,138 | 1,858 | -1,654 | -2,294 |
| Accounts receivable | 27,821 | 15,892 | -56,591 | 2,227 | 2,448 |
| Accounts payable and accrued liabilities | -883 | 1,791 | 1,317 | 633 | 1,451 |
| Other Working Capital | 12,900 | 11,491 | -61,787 | 21,970 | 6,171 |
| Other Operating Activity | -11,138 | 77 | 70,784 | 8,928 | 3,195 |
| Operating Cash Flow | $7,088 | $71,418 | $29,220 | $52,653 | $35,809 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,445 | -5,417 | -2,981 | -2,506 | -4,738 |
| Purchase Of Investment | -338,553 | -549,312 | -293,103 | -251,371 | -192,429 |
| Sale Of Investment | 359,828 | 468,065 | 260,682 | 249,305 | 153,504 |
| Investing Cash Flow | $19,830 | $-86,664 | $-35,402 | $-4,572 | $-43,663 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -86 | -79 | -73 | -68 |
| Common Stock Issued | 10,481 | 6,848 | 6,244 | 1,079 | 1,026 |
| Other Financing Activity | -1,498 | -4,188 | -1,756 | 11 | 1,747 |
| Financing Cash Flow | $8,983 | $2,574 | $4,409 | $1,017 | $2,705 |
| Beginning Cash Position | 51,838 | 64,510 | 66,283 | 17,185 | 21,726 |
| End Cash Position | 87,739 | 51,838 | 64,510 | 66,283 | 16,577 |
| Net Cash Flow | $35,901 | $-12,672 | $-1,773 | $49,098 | $-5,149 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,088 | 71,418 | 29,220 | 52,653 | 35,809 |
| Capital Expenditure | -1,445 | -5,417 | -2,981 | -2,506 | -4,738 |
| Free Cash Flow | 5,643 | 66,001 | 26,239 | 50,147 | 31,071 |